4.2 Article

Inhibition of TNF-α-induced Cyclooxygenase-2 Expression by Mycobacterium bovis BCG in Human Alveolar Epithelial A549 Cells

Journal

SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Volume 69, Issue 1, Pages 11-19

Publisher

WILEY
DOI: 10.1111/j.1365-3083.2008.02190.x

Keywords

-

Categories

Funding

  1. Department of Biotechnology
  2. Department of Science and Technology (DST)
  3. Council for Scientific and Industrial Research (CSIR), Government of India
  4. ICMR (Center for Advanced Study in Molecular Medicine)
  5. University Grants Commission

Ask authors/readers for more resources

Cyclooxygenase-2 (COX-2) is implicated in pathophysiological processes associated with the initiation or maintenance of host inflammatory responses to infection. Our results demonstrates that Mycobacterium bovis BCG (M. bovis BCG) downregulates tumour necrosis factor-alpha (TNF-alpha)-induced COX-2 gene expression in alveolar epithelial cells by inhibiting the phosphorylations of Raf-1 and p38 kinases. Further, M. bovis BCG-mediated inhibition of COX-2 or p38 mitogen-activated protein kinase could be reversed by Calyculin A, a selective inhibitor of Ser/Thr phosphatases. Moreover, M. bovis BCG inhibited the TNF-alpha-triggered NF-kappa B activation following I kappa B degradation. Taken together, these results suggest that the attenuation of COX-2 expression by vaccine strain, M. bovis BCG, represents a novel strategy to maintain robust host proinflammatory responses to subsequent challenges with virulent tuberculosis bacilli.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available